|
N =251/group
| |
Group A (RA)
|
Group B (DM)
|
Group C (GP)
|
P; All three
|
P; A versus C
|
|---|
|
Age
|
Years (SD)
|
48.5 (10.0)
|
49.1 (9.8)
|
49.0 (9.3)
|
0.8
| |
|
Gender
|
Male
|
47 (19%)
|
47 (19%)
|
47 (19%)
|
1
| |
| |
Female
|
204 (81%)
|
204 (81%)
|
204 (81%)
| | |
|
Race
|
Caucasian
|
203 (81%)
|
203 (81%)
|
203 (81%)
| | |
| |
African-American
|
27 (11%)
|
27 (11%)
|
27 (11%)
| | |
| |
Asian
|
17 (7%)
|
17 (7%)
|
17 (7%)
| | |
| |
Other
|
4 (< 2%)
|
4 (< 2%)
|
4 (< 2%)
| | |
|
Disease duration
|
Years (SD)
|
10.0 (8.4)
|
9.3 (9.0)
|
N/A
|
0.08
|
N/A
|
|
Personal history
|
HTN
|
71 (28%)
|
130 (52%)
|
71 (28%)
|
< 0.0001
|
1
|
| |
HL
|
55 (22%)
|
114 (45%)
|
48 (19%)
|
< 0.0001
|
0.5
|
| |
CAD
|
5 (2%)
|
27 (11%)
|
6 (2%)
|
< 0.0001
|
1
|
| |
MI
|
5 (2%)
|
12 (5%)
|
2 (1%)
|
.01
|
0.4
|
| |
CVA
|
4 (2%)
|
14 (6%)
|
4 (2%)
|
.009
|
1
|
|
Family history
|
CAD
|
74 (30%)
|
95 (38%)
|
62 (25%)
|
0.005
|
0.3
|
| |
MI
|
30 (12%)
|
49 (20%)
|
28 (11%)
|
0.012
|
0.9
|
| |
CVA
|
35 (14%)
|
25 (10%)
|
25 (10%)
|
0.3
|
0.2
|
|
CRP
| |
0.9
|
N/A
|
N/A
| | |
|
Hemoglobin A1c
| |
N/A
|
7.5
|
N/A
| | |
- CAD, coronary artery disease; CRP, C-reactive protein; CVA, cerebrovascular accident; DM, diabetes mellitus; GP, general population; HL, hyperlipidemia; HTN, hypertension; MI, myocardial infarction; N/A, not applicable; RA, rheumatoid arthritis.
